| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/03/2009 | WO2009107158A1 Monospecific antibody and method of production using as antigen an isoform of the human fad synthetase. |
| 09/03/2009 | WO2009107129A1 Immunoglobulin compositions and methods of producing same |
| 09/03/2009 | WO2009106773A2 Transgenic non-human mammal for the constant region of the g-class human immunoglobulin heavy chain and applications thereof |
| 09/03/2009 | WO2009106579A1 Methods for prognosing the status of tumor patients |
| 09/03/2009 | WO2009106356A1 Monoclonal antibodies against the rgm a protein and uses thereof |
| 09/03/2009 | WO2009106321A1 Treatment of resistant tumors with trifunctional antibodies |
| 09/03/2009 | WO2009106096A1 Treatment of resistant tumors with trifunctional antibodies |
| 09/03/2009 | WO2009105934A1 Monoclonal antibody anti-human rankl |
| 09/03/2009 | WO2009087462A3 Ephrin type-a receptor 10 protein |
| 09/03/2009 | WO2009071696A3 Humanized antibody molecules specific for il-31 |
| 09/03/2009 | WO2009067520A3 Peptides specific for hepatocellular carcinoma cells and applications thereof |
| 09/03/2009 | WO2009064777A3 Production of fc-fusion polypeptides in eukaryotic algae |
| 09/03/2009 | WO2009064321A3 Biomarker detection |
| 09/03/2009 | WO2009061996A3 Antibodies that bind human dendritic and epithelial cell 205 (dec-205) |
| 09/03/2009 | WO2009055669A3 Monoclonal antibodies against activated and unactivated protein c |
| 09/03/2009 | WO2009048537A3 Humanized antibody |
| 09/03/2009 | WO2009004065A3 Providing improved immunoglobulin sequences by mutating cdr and/or fr positions |
| 09/03/2009 | WO2008146133A8 Hematopoietic cells that express mosc-1 |
| 09/03/2009 | WO2008120202A9 Antibodies, methods and kits for diagnosing and treating melanoma |
| 09/03/2009 | WO2004084841A3 Novel anti-feline albumin antibodies and methods of detecting early renal disease |
| 09/03/2009 | US20090222931 Novel identified oncogene with kinase-domain (nok) |
| 09/03/2009 | US20090221804 GBS Toxin Receptor Compositions and Methods of Use |
| 09/03/2009 | US20090221802 heterodimeric receptor complex comprising a receptor polypeptide and a interleukin-2 gamma receptor polypeptide, used for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo; antibodies; immunology |
| 09/03/2009 | US20090221793 Process for preparing a pentopyranosyl nucleic acid conjugate |
| 09/03/2009 | US20090221718 Metadherin polypeptides, encoding nucleic acids and methods of use |
| 09/03/2009 | US20090221677 Methods for Reducing Body Fat and Increasing Lean Body Mass by Reducing Stearoyl-COA Desaturase 1 Activity |
| 09/03/2009 | US20090221672 Biomarker for Prostate Cancer |
| 09/03/2009 | US20090221670 Method for diagnosis and treatment of a mental disease |
| 09/03/2009 | US20090221507 administering peptide sequence tyr-ser-met-lys-lys-thr-thr-met-lys-ile-ile-pro-phe-asn-arg-leu-thr-ile-gly to a mammal to treat degenerative disorder of the nervous system involves leakage of fibrinogen perivascularly in the brain; multiple sclerosis, spinal cord injury, stroke and Alzheimer's Disease |
| 09/03/2009 | US20090221506 Gdnf derived peptides |
| 09/03/2009 | US20090221505 Compositions and methods related to synchronous selection of homing peptides for multiple tissues by in vivo phage display |
| 09/03/2009 | US20090221483 Antimicrobial Cathelicidin Peptides |
| 09/03/2009 | US20090221478 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 09/03/2009 | US20090221097 Method or agent for inhibiting the function of efflux pump of pseudomonas aeruginosa |
| 09/03/2009 | US20090221094 Anthrax Polypeptide Binding |
| 09/03/2009 | US20090221074 Conductive polymer matrix and device for use in the efficient isolation of preferential stem cells; permits the monitoring of cell binding to the solid matrix during the selection process, it is possible to obtain feedback information on the number of selected cells at any time |
| 09/03/2009 | US20090221066 Anti-Methylated Dna Antibody and Method for Production Thereof |
| 09/03/2009 | US20090221040 immunizing an animal with a mixture of different histidine fusion polypeptides and obtaining polyclonal antibodies directed against the histidine portion of the fusion polypeptides from the serum of the animal; rapid |
| 09/03/2009 | US20090221036 Recombinant anti-cd4 antibodies for human therapy |
| 09/03/2009 | US20090221031 Novel group of esterases for the production of fine and speciality chemicals |
| 09/03/2009 | US20090221004 Caspase-cleavage anti-keratin antibodies for detection of apoptosis |
| 09/03/2009 | US20090221003 Procedure for the generation of a high producer cell line for the expression of a recombinant anti-cd34 antibody |
| 09/03/2009 | US20090220999 Antibodies immunoreactive with mutant 5-enolpyruvlshikimate-3-phosphate synthase |
| 09/03/2009 | US20090220991 Reagents for the detection of protein phosphorylation in leukemia signaling pathways |
| 09/03/2009 | US20090220977 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 09/03/2009 | US20090220962 Nucleotide sequences coding cyanopeptide metabolites for potential use as angiotensin converting enzyme inhibitors and in treatment of aterial stenosis and high blood pressure |
| 09/03/2009 | US20090220536 HIV vaccine immunogens and immunization strategies to elicit broadly-neutralizing anti-HIV-1 antibodies against the membrane proximal domain of HIV GP41 |
| 09/03/2009 | US20090220527 Affinity optimized epha2 agonistic antibodies and methods of use thereof |
| 09/03/2009 | US20090220525 Novel Bacterium and Vaccine |
| 09/03/2009 | US20090220524 Therapeutic agents for alzheimer's disease and cancer |
| 09/03/2009 | US20090220522 Detoxified Endotoxin Vaccine and Adjuvant and Uses thereof |
| 09/03/2009 | US20090220521 Anti MIF Antibodies |
| 09/03/2009 | US20090220520 Recombinant method for the production of a monoclonal antibody to CD52 for the treatment of chronic lymphocytic leukemia |
| 09/03/2009 | US20090220513 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 09/03/2009 | US20090220511 human polypeptides named IFN (interferon)- lambda 1, IFN- lambda 2 and IFN- lambda 3 and IFN- lambda R1; antiviral agents |
| 09/03/2009 | US20090220510 Recognize aberrant glycosylated form of the EGFR; evident upon aberrant post-translational modification; cancer |
| 09/03/2009 | US20090220509 Singlec-9 binding agents |
| 09/03/2009 | US20090220505 Methods of inhibiting amyloid toxicity |
| 09/03/2009 | US20090220504 Combinatorial therapy |
| 09/03/2009 | US20090220502 B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS |
| 09/03/2009 | US20090220501 Anti-CD19 Antibody, Immunotoxin and Treatment Method |
| 09/03/2009 | US20090220498 Method for Discovering Inhibitors of the Epstein-Barr Virus-Induced Gene 3 (EBI3) and Derivatives Thereof for the Treatment of Metastasizing Tumors and Allergic Asthma |
| 09/03/2009 | US20090220495 Cancer Related Genes (PRLR) |
| 09/03/2009 | US20090220494 Antibodies produced in a transgenic avian |
| 09/03/2009 | US20090220493 Reagents and methods for inducing an immune response to prostate specific antigen |
| 09/03/2009 | US20090220492 Protein purification |
| 09/03/2009 | US20090220490 Compositions and Assays for Inhibiting HCV Infection |
| 09/03/2009 | US20090220489 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| 09/03/2009 | US20090220486 Antibodies and uses thereof |
| 09/03/2009 | US20090220485 Method for isolation of soluble polypeptides |
| 09/03/2009 | US20090220484 Rage/Diaphanous Interaction and Related Compositions and Methods |
| 09/03/2009 | US20090220479 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart disease |
| 09/03/2009 | US20090220452 Method Of Producing A Modified (POLY) Peptide |
| 09/03/2009 | US20090220424 Pro104 Antibody Compositions and Methods of Use |
| 09/03/2009 | CA2717036A1 Methods for prognosing the status of tumor patients |
| 09/03/2009 | CA2715456A1 Monoclonal antibodies against the rgm a protein and uses thereof |
| 09/02/2009 | EP2096438A1 Methods for prognosing the status of patients |
| 09/02/2009 | EP2096172A2 Genetic sequences having methyltransferase activity and uses therefor |
| 09/02/2009 | EP2096168A1 Diagnostic agent for mesothelioma, diagnosis kit for mesothelioma, and diagnosis method for mesothelioma |
| 09/02/2009 | EP2096122A1 Anti-human dlk-1 antibody showing anti-tumor activity in vivo |
| 09/02/2009 | EP2096121A1 Antiviral peptides comprising lipid attachment signals and methods of use |
| 09/02/2009 | EP2095873A1 Isolation of immunoglobulins |
| 09/02/2009 | EP2095827A1 High affinity human monoclonal antibodies specific for RSV F-protein |
| 09/02/2009 | EP2095826A1 Nerve elongation promoter and elongation inhibitor |
| 09/02/2009 | EP2094832A1 Methods and compositions for reducing amyloid beta levels |
| 09/02/2009 | EP2094733A1 Fgfr4 antibodies |
| 09/02/2009 | EP2094732A2 Dr6 antibodies inhibiting the binding of dr6 to app, and uses thereof in treating neurological disorders |
| 09/02/2009 | EP2094731A2 Anti human sclerostin antibodies |
| 09/02/2009 | EP2094730A2 Methods and materials related to anti-amyloid antibodies |
| 09/02/2009 | EP2094729A1 Abeta antibody parenteral formulation |
| 09/02/2009 | EP2094728A2 Methods for use in human-adapting monoclonal antibodies |
| 09/02/2009 | EP2094725A1 Variants and methods of using transforming growth factor beta-9 |
| 09/02/2009 | EP2094660A2 Immunochemically equivalent hiv drug analogs |
| 09/02/2009 | EP2094307A2 Tes7 and antibodies that bind thereto |
| 09/02/2009 | EP2094303A1 Treatment of diabetes by at least one epidermal growth factor receptor specific antibody or a derivative thereof |
| 09/02/2009 | EP2094302A2 Methods for the treatment of lada and other adult-onset autoimmune diabetes using immunosuppressive monoclonal antibodies with reduced toxicity |
| 09/02/2009 | EP2094288A2 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 09/02/2009 | EP2094282A2 Anti-tsg101 antibodies and their uses for treatment of viral infections |
| 09/02/2009 | EP2094279A2 Methods and compositions for treating influenza |
| 09/02/2009 | EP1601770B1 Streptococcus pyogenes antigens |